Kura Oncology (KURA) Cash from Investing Activities (2014 - 2026)
Kura Oncology (KURA) reported Cash from Investing Activities of -$24.2 million for Q1 2026, up 76.11% year-over-year from -$13.8 million in Q1 2025, and up 62.49% on a QoQ basis from -$64.6 million in Q4 2025.
Kura Oncology (KURA) has 13 years of Cash from Investing Activities data on file, last reported at -$24.2 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 76.11% year-over-year to -$24.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.1 million (up 159.52% YoY) and the FY2025 annual result came in at -$13.1 million, up 87.11% from the prior year.
- Cash from Investing Activities grew to -$24.2 million in Q1 2026 per KURA's latest filing, from -$64.6 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $94.0 million in Q3 2025 and bottomed at -$101.4 million in Q1 2025.
- The 5-year median for Cash from Investing Activities is $8.6 million (2023), against an average of -$5.3 million.
- Peak annual rise in Cash from Investing Activities reached 432.01% in 2024, while the deepest fall reached 956.65% in 2024.
- Tracing KURA's Cash from Investing Activities over 5 years: stood at -$47.3 million in 2022, then surged by 189.17% to $42.2 million in 2023, then sank by 325.04% to -$95.0 million in 2024, then jumped by 31.97% to -$64.6 million in 2025, then soared by 62.49% to -$24.2 million in 2026.
- Per Business Quant, the three latest KURA Cash from Investing Activities figures stand at -$24.2 million (Q1 2026), -$64.6 million (Q4 2025), and $94.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | -24.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.23 Mn |
| Mar 31, 2026 | -24.23 Mn |
| Dec 31, 2025 | -64.60 Mn |
| Dec 31, 2025 | -64.60 Mn |
| Sep 30, 2025 | 93.97 Mn |
| Sep 30, 2025 | 93.97 Mn |
| Jun 30, 2025 | 58.94 Mn |
| Jun 30, 2025 | 58.94 Mn |
| Mar 31, 2025 | -101.41 Mn |
| Mar 31, 2025 | -101.41 Mn |
| Dec 31, 2024 | -94.96 Mn |
| Dec 31, 2024 | -94.96 Mn |
| Sep 30, 2024 | 45.54 Mn |
| Sep 30, 2024 | 45.54 Mn |
| Jun 30, 2024 | 43.17 Mn |
| Jun 30, 2024 | 43.17 Mn |
| Mar 31, 2024 | -95.34 Mn |
| Mar 31, 2024 | -95.34 Mn |
| Dec 31, 2023 | 42.20 Mn |
| Dec 31, 2023 | 42.20 Mn |
| Sep 30, 2023 | 8.56 Mn |
| Sep 30, 2023 | 8.56 Mn |
| Jun 30, 2023 | -46.33 Mn |
| Jun 30, 2023 | -46.33 Mn |
| Mar 31, 2023 | 11.13 Mn |
| Mar 31, 2023 | 11.13 Mn |
| Dec 31, 2022 | -47.32 Mn |
| Dec 31, 2022 | -47.32 Mn |
| Sep 30, 2022 | 71.81 Mn |
| Sep 30, 2022 | 71.81 Mn |
| Jun 30, 2022 | 33.10 Mn |
| Jun 30, 2022 | 33.10 Mn |
| Mar 31, 2022 | -24.96 Mn |
| Mar 31, 2022 | -24.96 Mn |
| Dec 31, 2021 | 74.06 Mn |
| Dec 31, 2021 | 74.06 Mn |
| Sep 30, 2021 | 22.55 Mn |
| Sep 30, 2021 | 22.55 Mn |
| Jun 30, 2021 | -37.22 Mn |
| Jun 30, 2021 | -37.22 Mn |
| Mar 31, 2021 | -186.22 Mn |
| Mar 31, 2021 | -186.22 Mn |
| Dec 31, 2020 | -60.19 Mn |
| Dec 31, 2020 | -60.19 Mn |
| Sep 30, 2020 | -45.52 Mn |
| Sep 30, 2020 | -45.52 Mn |
| Jun 30, 2020 | -21.69 Mn |
| Jun 30, 2020 | -21.69 Mn |
| Mar 31, 2020 | 27.46 Mn |
| Mar 31, 2020 | 27.46 Mn |
| Dec 31, 2019 | -15.26 Mn |
| Dec 31, 2019 | -15.26 Mn |
| Sep 30, 2019 | -55.75 Mn |
| Sep 30, 2019 | -55.75 Mn |
| Jun 30, 2019 | 8.88 Mn |
| Jun 30, 2019 | 8.88 Mn |
| Mar 31, 2019 | 15.81 Mn |
| Mar 31, 2019 | 15.81 Mn |
| Dec 31, 2018 | 4.62 Mn |
| Dec 31, 2018 | 4.62 Mn |
| Sep 30, 2018 | -58.06 Mn |
| Sep 30, 2018 | -58.06 Mn |
| Jun 30, 2018 | 3.86 Mn |
| Jun 30, 2018 | 3.86 Mn |
| Mar 31, 2018 | -29.71 Mn |
| Mar 31, 2018 | -29.71 Mn |
| Dec 31, 2017 | -4.09 Mn |
| Dec 31, 2017 | -4.09 Mn |
| Sep 30, 2017 | -36.29 Mn |
| Sep 30, 2017 | -36.29 Mn |
| Jun 30, 2017 | 7.43 Mn |
| Jun 30, 2017 | 7.43 Mn |
| Mar 31, 2017 | 9.53 Mn |
| Mar 31, 2017 | 9.53 Mn |
| Dec 31, 2016 | 9.68 Mn |
| Dec 31, 2016 | 9.68 Mn |
| Sep 30, 2016 | 143,000.00 |
| Sep 30, 2016 | 143,000.00 |
| Jun 30, 2016 | -5.84 Mn |
| Jun 30, 2016 | -5.84 Mn |
| Mar 31, 2016 | 8.20 Mn |
| Mar 31, 2016 | 8.20 Mn |
| Dec 31, 2015 | -40.45 Mn |
| Dec 31, 2015 | -40.45 Mn |
| Sep 30, 2015 | -3.89 Mn |
| Sep 30, 2015 | -3.89 Mn |
| Jun 30, 2015 | -26.28 Mn |
| Jun 30, 2015 | -26.28 Mn |
| Mar 31, 2015 | -10,000.00 |
| Mar 31, 2015 | -10,000.00 |
| Dec 31, 2014 | -28,000.00 |
| Dec 31, 2014 | -28,000.00 |
| Sep 30, 2014 | -11,000.00 |
| Sep 30, 2014 | -11,000.00 |